Biotech - Press Releases

Date	Title	Company
15-Nov-2019	Kayentis opens Japanese subsidiary to support growth of Asia-Pacific clinical trials sector	Kayentis
15-Nov-2019	Nordic Nanovector to participate in four upcoming investor conferences	Nordic Nanovector ASA
15-Nov-2019	Tulip Diagnostics to Acquire Biosense Technologies in India - Extends Capabilities in Point-of-Care Diagnostics	Tulip Diagnostics
15-Nov-2019	Creative Diagnostics Introduces New Foodborne Pathogen Antibodies and Antigens	Creative Diagnostics
15-Nov-2019	Viva Biotech Partnership Summit Successfully Launched in Shanghai	Viva Biotech
14-Nov-2019	FDA approves new antibacterial drug to treat complicated urinary tract infections as part of ongoing efforts to address antimicrobial resistance	U.S. Food and Drug Administration
14-Nov-2019	RTI International Announces Follow-On Investment in Precision Medicine Company PierianDX	RTI International
14-Nov-2019	South African start-up named Africa Challenge winner for its mission to eradicate malaria	ERADA Technology Alliance Ltd
14-Nov-2019	BioMarin Announces Cumulative Additional Height Gain of 9.0 cm over 54 months versus Natural History in Children with Achondroplasia Treated with Vosoritide in Phase 2 Study	BioMarin Pharmaceutical Inc.
14-Nov-2019	New Bespoke service for small and emerging Pharma and Biotech companies	G&L Scientific
14-Nov-2019	APPOINTMENT OF JOINT BROKER	ValiRx
14-Nov-2019	Helsinn supported ‘70 Years of Cancer Care in China’ celebratory event in Shanghai	Helsinn Group
14-Nov-2019	Phase 3 Results of Bavarian Nordic’s Smallpox Vaccine Published in The New England Journal of Medicine	Bavarian Nordic A/S
14-Nov-2019	Theragnostics Strengthens Leadership Team with Two Key Appointments	Theragnostics
14-Nov-2019	World's First Candidate Antibody Treatment for Yellow Fever, Developed by Tychan, Tested Safe and Effective in Human Volunteers	Tychan
13-Nov-2019	CNS Pharmaceuticals Announces Closing Of Initial Public Offering of Common Stock	CNS Pharmaceuticals, Inc.
13-Nov-2019	Kjell G. Stenberg Steps Down as CEO of Cyxone	Cyxone
13-Nov-2019	Autolus Therapeutics and Noile-Immune Announce Licensing Agreement	Autolus Therapeutics plc
13-Nov-2019	XBiotech Announces First Patient Enrolled in Placebo-Controlled Clinical Study Evaluating Its anti-IL-1⍺ Therapy Bermekimab in Patients with Atopic Dermatitis (Eczema)	XBiotech Inc
13-Nov-2019	UNKNOWN VIRUS DISCOVERED IN HUMAN BODY	University of Health Sciences